News | Quality Assurance (QA) | July 08, 2019

PTW to Feature New Dosimetry Technology at AAPM 2019

Offerings will include new water phantom for MR-guided radiotherapy, modular patient and machine QA systems

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

July 8, 2019 — At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will exhibit its full range of dosimetry solutions for magnetic resonance-guided radiotherapy (MRgRT), beam data commissioning and stereotactic quality assurance (QA).

PTW will exhibit and demonstrate its latest technology and most recent product developments including:

  • Beamscan MR 3-D water phantom – The first 3-D water phantom for MR-guided radiotherapy, according to the company, available in two models for Elekta Unity and ViewRay MRIdian. Beamscan MR 3-D is pending U.S. Food and Drug Administration (FDA) 510(k) clearance and is not available for sale in the U.S.;
  • Beamscan 3-D water phantom – Fast to set up and easy to use for all acceptance testing and commissioning needs, now available for the Halcyon system;
  • Octavius 4-D modular patient and machine QA systems – For the latest radiotherapy techniques, including Halcyon, stereotactic radiosurgery (SRS) and MRgRT. Also introducing Octavius Detector 1600 SRS for 3-D dose verification of complex SRS/SBRT (stereotactic body radiation therapy) treatment plans;
  • Ruby phantom – A new modular stereotactic verification phantom with multiple inserts for comprehensive system QA, linear accelerator (linac) QA and patient QA:
  • StarCheck arrays – High-resolution ionization chamber arrays for comprehensive, TG-142-compliant linac QA, available in three models for standard (25 x 25 cm²), large (40 x 40 cm²) and magnetic fields;
  • microSilicon diode detector – The new silicon diode detector for small photon and all electron fields; and
  • Track-it 2.0 QA data management software – Versatile, web-based QA data management software that integrates QA data from different sources, devices and sites into a single platform.

PTW is hosting a Lunch and Learn symposium for AAPM attendees on Monday, July 15. The event will feature the following presenters:

  • Jochem Wolthaus, Ph.D., a medical physicist at the University Medical Center Utrecht, will present “The Development and Experience of the first MR-compatible 3-D Scanning Water Tank for Acceptance, Commissioning and QA measurements in an MRI-LINAC”; 
  • Dan Nicewonger, a medical physicist at the MD Anderson Cancer Center in San Antonio, will present “QA Data Flow in Modern Radiotherapy Departments”; and
  • Sharon Thompson, a medical physicist from the Maimonides Cancer Center, Brooklyn, N.Y., will present “Challenges of Beam Data Collection and Validation of Halcyon during Commissioning.”

For more information:

Related Content

Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association

Getty Images

News | Prostate Cancer | September 08, 2020
September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the h
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic.

Getty Images

News | Coronavirus (COVID-19) | August 19, 2020
August 19, 2020 — The...
Smoking is strongly linked to lower use of cancer screening services by women, and more advanced disease once cancer is diagnosed, reveals research published in the online journal BMJ Open.

Getty Images

News | Lung Imaging | August 14, 2020
August 14, 2020 — Smoking is strongly linked to lower use of...
The first and only FDA-approved gadolinium-based contrast agent for multi-patient dosing with an FDA-cleared Transfer Spike in the MR suite
News | Contrast Media | August 14, 2020
August 14, 2020 — The U.S.